Switching patients from blinded study drug to warfarin at the end of the ENGAGE AF-TIMI 48 trial: setting a new standard

Affiliations

• ¹ David Braley Cardiac, Vascular, & Stroke Research Institute, Hamilton General Hospital, Hamilton, Ontario, Canada; Hamilton General Hospital, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Electronic address: eikelbj@mcmaster.ca.
• ² David Braley Cardiac, Vascular, & Stroke Research Institute, Hamilton General Hospital, Hamilton, Ontario, Canada.
• ³ David Braley Cardiac, Vascular, & Stroke Research Institute, Hamilton General Hospital, Hamilton, Ontario, Canada; Hamilton General Hospital, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.